Clinical Trial Update: Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on panobinostat in combination with idarubicin and cytarabine in older adults with newly diagnosed acute myeloblastic leukemia (AML) acros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Idarubicin (idarubicin)
• Panobinostat (Panobinostat)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Acute Myeloblastic Leukaemia | Phase 1, Phase 2 | Status: COMPLETED